Search the collection

5 results for Xu,+Binghe,+Prof

Sort by:

Sort by

Limit results to:

20 per page

5 results for Xu,+Binghe,+Prof

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
Author / Creator:Xu, Binghe, Prof ; Yan, Min, Prof ; Ma, Fei, Prof ; Hu, Xichun, Prof ; Feng, Jifeng, Prof ; Ouyang, Quchang, Prof ; Tong, Zhongsheng, Prof ; Li, Huiping, Prof ; Zhang, Qingyuan, Prof ; Sun, Tao, Prof ; Wang, Xian, MD ; Yin, Yongmei, Prof ; Cheng, Ying, Prof ; Li, Wei, Prof ; Gu, Yuanting, Prof ; Chen, Qianjun, Prof ; Liu, Jinping, Prof ; Cheng, Jing, Prof ; Geng, Cuizhi, Prof ; Qin, Shukui, Prof ; Wang, Shusen, Prof ; Lu, Jinsong, Prof ; Shen, Kunwei, Prof ; Liu, Qiang, Prof ; Wang, Xiaojia, Prof ; Wang, Hong, Prof ; Luo, Ting, Prof ; Yang, Jin, Prof ; Wu, Yudong, Prof ; Yu, Zhiyong, Prof ; Zhu, Xiaoyu, MD ; Chen, Chunxia, MSc ; Zou, Jianjun, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2021-03, Vol.22 (3), p.351-360
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2...
Author / Creator:Zhang, Pin, Prof ; Zhang, Qingyuan, Prof ; Tong, Zhongsheng, Prof ; Sun, Tao, Prof ; Li, Wei, Prof ; Ouyang, Quchang, Prof ; Hu, Xichun, Prof ; Cheng, Ying, Prof ; Yan, Min, Prof ; Pan, Yueyin, Prof ; Teng, Yuee, Prof ; Yan, Xi, Prof ; Wang, Ying, Prof ; Xie, Weimin, Prof ; Zeng, Xiaohua, Prof ; Wang, Xiaojia, Prof ; Hu, Changlu, Prof ; Geng, Cuizhi, Prof ; Zhang, Hongwei, Prof ; Li, Wenxin, Prof ; Wu, Xinhong, Prof ; Zhong, Jincai, Prof ; Xu, Jingwei, Prof ; Shi, Yanxia, PhD ; Wei, Wenhua, PhD ; Bayaxi, Nayima, PhD ; Zhu, Xiaoyu, PhD ; Xu, Binghe, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2023-06, Vol.24 (6), p.646-657
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Author / Creator:André, Fabrice, Prof ; O'Regan, Ruth, Prof ; Ozguroglu, Mustafa, Prof ; Toi, Masakazu, Prof ; Xu, Binghe, Prof ; Jerusalem, Guy, Prof ; Masuda, Norikazu, MD ; Wilks, Sharon, MD ; Arena, Francis, MD ; Isaacs, Claudine, Prof ; Yap, Yoon-Sim, MD ; Papai, Zsuzsanna, MD ; Lang, Istvan, Prof ; Armstrong, Anne, MD ; Lerzo, Guillermo, MD ; White, Michelle, MD ; Shen, Kunwei, Prof ; Litton, Jennifer, MD ; Chen, David, PhD ; Zhang, Yufen, PhD ; Ali, Shyanne ; Taran, Tetiana, MD ; Gianni, Luca, Dr
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2014-05, Vol.15 (6), p.580-591
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Accelerating the integration of China into the global development of innovative anticancer drugs
Author / Creator:Huang, Huiyao, Prof ; Wu, Dawei, MD ; Miao, Huilei, MD ; Tang, Yu, Prof ; Liu, Chengcheng, PhD ; Fang, Hong, MPharm ; Meng, Xinyu, MBIOS ; Wang, Shuhang, Prof ; Zhu, Qi, MPharm ; Wang, Xin, Prof ; Du, Jingting, MPharm ; Yang, Zhimin, Prof ; Li, Ning, Prof ; Xu, Binghe, Prof ; He, Jie, Prof
Publisher:London: Elsevier Ltd
Journal title:The lancet oncology, 2022-11, Vol.23 (11), p.e515-e520
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomi...
Author / Creator:Zhang, Pin, Prof ; Sun, Tao, Prof ; Zhang, Qingyuan, Prof ; Yuan, Zhongyu, Prof ; Jiang, Zefei, Prof ; Wang, Xiao Jia, Prof ; Cui, Shude, Prof ; Teng, Yuee, Prof ; Hu, Xi-Chun, Prof ; Yang, Junlan, Prof ; Pan, Hongming, Prof ; Tong, Zhongsheng, Prof ; Li, Huiping, Prof ; Yao, Qiang, Prof ; Wang, Yongsheng, Prof ; Yin, Yongmei, Prof ; Sun, Ping, Prof ; Zheng, Hong, Prof ; Cheng, Jing, Prof ; Lu, Jinsong, Prof ; Zhang, Baochun, MD ; Geng, Cuizhi, Prof ; Liu, Jian, Prof ; Peng, Roujun, MD ; Yan, Min, MD ; Zhang, Shaohua, MD ; Huang, Jian, MD ; Tang, Li, PhD ; Qiu, Rongguo, PhD ; Xu, Binghe, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2017-03, Vol.18 (3), p.371-383
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Export this record

Export record to excel

Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2...

Export this record

Export record to excel

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

Export this record

Export record to excel

Accelerating the integration of China into the global development of innovative anticancer drugs

Export this record

Export record to excel

Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomi...

Refine your search